Author
Listed:
- Emma C. Josefsson
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Deborah L. Burnett
(The Walter and Eliza Hall Institute of Medical Research
The University of Sydney)
- Marion Lebois
(The Walter and Eliza Hall Institute of Medical Research)
- Marlyse A. Debrincat
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Michael J. White
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Katya J. Henley
(The Walter and Eliza Hall Institute of Medical Research)
- Rachael M. Lane
(The Walter and Eliza Hall Institute of Medical Research)
- Diane Moujalled
(The Walter and Eliza Hall Institute of Medical Research)
- Simon P. Preston
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Lorraine A. O’Reilly
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Marc Pellegrini
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Donald Metcalf
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Andreas Strasser
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Benjamin T. Kile
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
Abstract
BH3 mimetic drugs that target BCL-2 family pro-survival proteins to induce tumour cell apoptosis represent a new era in cancer therapy. Clinical trials of navitoclax (ABT-263, which targets BCL-2, BCL-XL and BCL-W) have shown great promise, but encountered dose-limiting thrombocytopenia. Recent work has demonstrated that this is due to the inhibition of BCL-XL, which is essential for platelet survival. These findings raise new questions about the established model of platelet shedding by megakaryocytes, which is thought to be an apoptotic process. Here we generate mice with megakaryocyte-specific deletions of the essential mediators of extrinsic (Caspase-8) and intrinsic (BAK/BAX) apoptosis. We show that megakaryocytes possess a Fas ligand-inducible extrinsic apoptosis pathway. However, Fas activation does not stimulate platelet production, rather, it triggers Caspase-8-mediated killing. Combined loss of Caspase-8/BAK/BAX does not impair thrombopoiesis, but can protect megakaryocytes from death in mice infected with lymphocytic choriomeningitis virus. Thus, apoptosis is dispensable for platelet biogenesis.
Suggested Citation
Emma C. Josefsson & Deborah L. Burnett & Marion Lebois & Marlyse A. Debrincat & Michael J. White & Katya J. Henley & Rachael M. Lane & Diane Moujalled & Simon P. Preston & Lorraine A. O’Reilly & Marc , 2014.
"Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways,"
Nature Communications, Nature, vol. 5(1), pages 1-14, May.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4455
DOI: 10.1038/ncomms4455
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4455. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.